| Delaware                        | 90-0535563          |
|---------------------------------|---------------------|
| (State or other jurisdiction of | (I.R.S. Employer    |
| incorporation or organization)  | Identification No.) |

| 3655 Nobel Drive, Suite 520                         |
|-----------------------------------------------------|
| San Diego, California 92122                         |
| (Address of principal executive offices) (zip code) |

| (858) 735-8865                                       |
|------------------------------------------------------|
| (Registrant's telephone number, including area code) |

| Large accelerated filer                       | Accelerated Filer           |
|-----------------------------------------------|-----------------------------|
| Non-accelerated filer                         | Smaller reporting company x |
| (do not check if a smaller reporting company) |

|                                 |   | Outstanding at |       |
|--------------------------------------|--------|----------------|------------|
| Class                                |   | May 19, 2011   |       |
|                                 |   |           |       |
| Common Stock, par value $0.0001      |   |           | 36,870,388 |   |
|                                 |   |           |       |   |
| Documents incorporated by reference: |   | None           |       |

----

|                                                                                                                                                       |   | As of     |     |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------|----------|
|                                                                                                                                                       |   | March 31, |     |   | December 31, |   |
|                                                                                                                                                       |   | 2011           |     |   | 2010 |   |
|                                                                                                                                                       |   | (Unaudited)    |     |   | (Audited) |   |
| Assets:                                                                                                                                                    |   |           |     |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |
| Current Assets:                                                                                                                                            |   |           |     |   |   |   |
| Cash                                                                                                                                                       |   | $              | 343,706  |   |   | $ | 32,554 |   |
| Total current Assets                                                                                                                                       |   |           | 343,706  |   |   |   | 32,554 |   |
| Patents                                                                                                                                                    |   |           | 553      |   |   |   | 553 |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Total Assets                                                                                                                                               |   | $              | 344,259  |   |   | $ | 33,107 |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Liabilities and Shareholders' Equity:                                                                                                                      |   |           |     |   |   |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Current Liabilities:                                                                                                                                       |   |           |     |   |   |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Accrued interest                                                                                                                                           |   | $              | 11,696   |   |   |   | 4,930 |   |
| Accrued expense                                                                                                                                            |   |           | 2,250    |   |   | $ | 34,750 |   |
| Due to a related party                                                                                                                                     |   |           | 1,000    |   |   |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Total Current Liabilties                                                                                                                                   |   |           | 14,946   |   |   |   | 39,680 |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Borrowing from a related party                                                                                                                             |   |           | 549,955  |   |   |   | 149,970 |   |
| Total Liabilities                                                                                                                                          |   |           | 564,901  |   |   |   | 189,650 |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Shareholders' Equity;                                                                                                                                      |   |           |     |   |   |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Prefered stock, $ .0001 par value, 20,000,000 shares authorized, none issued and outstanding                                                               |   |           | -        |   |   |   |   |   |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Common Stock, $0.0001 par value, 250,000,000 shares authorized 36,870,388 issued and outstanding as of March 31, 2011 and December 31, 2010 , respectively |   | $              | 3,687    |   |   | $ | 3,687 |   |
| Paid-in capital                                                                                                                                            |   |           | 12,234   |   |   |   | 12,234 |   |
| Deficit during Development Stage                                                                                                                           |   |           | (236,563 | ) |   |   | (172,464 | ) |
|                                                                                                                                                       |   |           | (220,642 | ) |   |   | (156,543 | ) |
|                                                                                                                                                       |   |           |     |   |   |   |   |   |
| Total Liabilities and Shareholders' Equity                                                                                                                 |   | $              | 344,259  |   |   | $ | 33,107 |   |

----

|                                                |   |                |       |   | Cumulative since   |   |
|-----------------------------------------------------|--------|---------------------|------------|--------|-------------------------|--------|
|                                                |   | For the        |       |   | July 24, 2008 |   |
|                                                |   | 3-Months ended |       |   | (Inception)             |   |
|                                                |   | 3/31/2011           |       |   | 3/31/2010               |   |   | to 3/31/2011 |   |
|                                                |   |                |       |   |                    |   |   |   |   |
| Revenue                                             |   | $                   | -          |   |                    | $      | - |   |   | $ | - |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Operating Expenses:                                 |   |                |       |   |                    |   |   |   |   |   |   |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Legal, audit and other general & administrative |   |                | 57,333     |   |                    |   |   |   |   |   | 224,867 |   |
|                                                |   |                | -          |   |                    |   | - |   |   |   | - |   |
|                                                |   |                | 57,333     |   |                    |   | - |   |   |   | 224,867 |   |
| Total Expenses:                                     |   |                | 57,333     |   |                    |   | - |   |   |   | 224,867 |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Other income (loss)                                 |   |                |       |   |                    |   |   |   |   |   |   |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Interest expense                                    |   |                | 6,766      |   |                    |   |   |   |   |   | 11,696 |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Total other income (loss)                           |   |                |       |   |                    |   |   |   |   |   | (4,930 | ) |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Income ( Loss) before income taxes                  |   |                | (64,099    | )      |                    |   | - |   |   |   | (236,563 | ) |
| Provision for income taxes                          |   |                | -          |   |                    |   | - |   |   |   | - |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Net loss                                            |   | $                   | (64,099    | )      |                    | $      |  - |   |   | $ | (236,563 | ) |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Loss per share                                      |   |                | (0.002     | )      |                    |   | - |   |   |   |   |   |
|                                                |   |                |       |   |                    |   |   |   |   |   |   |   |
| Weighted average common shares ( basic and diluted) |   |                | 36,870,388 |   |                    |   | 31,340,000 |   |   |   |   |   |

----

|                                                      |   | Number ofCommonShares |       |   | Amount |   |   | AdditionalPaid-InCapital |   |   | DeficitAccumulatedduringdevelopmentstage |   |   | Total  |     |
|-----------------------------------------------------------|--------|----------------------------|------------|--------|--------|--------|--------|--------------------------|--------|--------|------------------------------------------|--------|--------|--------|----------|
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |
| Pre-Inception Balance                                     |   |                       | -          |   |   | $      | -      |                     |   | $      | -                                        |   |   | $      | -        |   |   | $ | - |   |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Common Stock Issued for services to founder on 07/24/2008 |   |                       | 31,340,000 |   |   |   | 3,134  |                     |   |   | -                                        |   |   |   | -        |   |   |   | 3,134 |   |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   | - |   |
| Net Loss for the Period                                   |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   | (3,134   | ) |   |   | (3,134 | ) |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Balance as of 12/31/2008 (Audited)                        |   |                       | 31,340,000 |   |   |   | 3,134  |                     |   |   | -                                        |   |   |   | (3,134   | ) |   |   | - |   |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Net Loss for the Period                                   |   |                       | -          |   |   |   | -      |                     |   |   | -                                        |   |   |   | -        |   |   |   | - |   |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Balance as of 12/31/2009 (Audited)                        |   |                       | 31,340,000 |   |   |   | 3,134  |                     |   |   | -                                        |   |   |   | (3,134   | ) |   |   | - |   |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Common Stock issued for assets purchase, 08/06/2010       |   |                       | 5,530,388  |   |   |   | 553    |                     |   |   | 12,234                                   |   |   |   | -        |   |   |   | 12,787 |   |
| Net Loss for the Year                                     |   |                       | -          |   |   |   | -      |                     |   |   | -                                        |   |   |   | (169,330 | ) |   |   | (169,330 | ) |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Balance as of 12/31/2010 (Audited)                        |   |                       | 36,870,388 |   |   | $      | 3,687  |                     |   | $      | 12,234                                   |   |   | $      | (172,464 | ) |   | $ | (156,543 | ) |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Net Loss for the 3-months period ended March 31, 2011     |   |                       | -          |   |   |   | -      |                     |   |   | -                                        |   |   |   | (64,099  | ) |   |   | (64,099 | ) |
|                                                      |   |                       |       |   |   |   |   |                     |   |   |                                     |   |   |   |     |   |   |   |   |   |
| Balance as of 03/31/2011 (Unaudited)                      |   |                       | 36,870,388 |   |   |   | 3,687  |                     |   |   | 12,234                                   |   |   |   | (236,563 | ) |   |   | (220,642 | ) |

----

|                                                                        |   |                     |    |   | Cumulative since   |   |
|-----------------------------------------------------------------------------|--------|--------------------------|---------|--------|-------------------------|--------|
|                                                                        |   | For the             |    |   | July 24, 2008 |   |
|                                                                        |   | 3 months ended |    |   | (Inception)             |   |
|                                                                        |   | 3/31/2011                |    |   | 3/31/2011               |   |   | to March 31, 2011 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |
| Cash Flows From Operating Activities                    |   |                     |    |   |                    |   |   |   |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |
| Net loss                                                                    |   | $                        | (64,099 | )      |                    | $      | - |   |   | $ | (236,563 | ) |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Adjustments to reconcile net income (loss) to net cash (used in) operations |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Common stock issued for service                                             |   |                     | -       |   |                    |   | - |   |   |   | 3,134 |   |
| Stock issued for purchase of assets                                         |   |                     |    |   |                    |   | - |   |   |   | 12,787 |   |
| Changes in operating assets and liailities                                  |   |                     |    |   |                    |   | - |   |   |   | - |   |
| Increase (decrease) in accrued interest                                     |   |                     | 6,766   |   |                    |   |   |   |   |   | 11,696 |   |
| Increase (decrease) in accrued expense                                      |   |                     | (31,500 | )      |                    |   |   |   |   |   | 3,250 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Net Cash provided by (used in) operations                                   |   |                     | (88,833 | )      |                    |   | - |   |   |   | (205,696 | ) |
|                                                                        |   |                     | -       |   |                    |   | - |   |   |   | - |   |
| Cash Flows From Investing Activities                                   |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Patents purchased in stocks                                                 |   |                     |    |   |                    |   |   |   |   |   | (553 | ) |
| Net cash provided by investing activities                                   |   |                     | -       |   |                    |   | - |   |   |   | (553 | ) |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Cash Flows From Financing Activities                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Stock issued for service                                                    |   |                     | -       |   |                    |   | - |   |   |   |   |   |
| Borrowing from a related party                                              |   |                     | 399,985 |   |                    |   |   |   |   |   | 549,955 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Net cash provided by financing activities                              |   |                     | 399,985 |   |                    |   | - |   |   |   | 549,955 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Net increase (decrease)                                                     |   |                     | 311,152 |   |                    |   | - |   |   |   | 343,706 |   |
| Cash at the Beginning of the Period:                                        |   |                     | 32,554  |   |                    |   | - |   |   |   | - |   |
| Cash at the End of the Period                                               |   | $                        | 343,706 |   |                    | $      | - |   |   | $ | 343,706 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Noncash transaction                                                         |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Common stocks issued for service                                            |   |                     |    |   |                    |   |   |   |   |   | 3,134 |   |
| Common stock issued for purchase of assets                                  |   | $                        | -       |   |                    | $      |   |   |   | $ | 553 |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Supplemental Disclosures of Cash Flow Information                           |   |                     |    |   |                    |   |   |   |   |   |   |   |
|                                                                        |   |                     |    |   |                    |   |   |   |   |   |   |   |
| Interest paid                                                               |   | $                        | 8,739   |   |                    | $      | - |   |   | $ | 13,669 |   |
| Income taxes paid                                                           |   | $                        | -       |   |                    | $      | - |   |   | $ | - |   |

----

----

----

| Creditor                                                     |   | Date ofOriginal Loan |   | Maturity Date |   | MaximumPrincipal |    | Interest Rate |                 | Balance asofDec 31,2010 |   |
|--------------------------------------------------------------|--------|--------------------------------|--------|--------------------|--------|------------------|---------|--------------------|----------------------|-----------------------------------|--------|
| Meridian World Trading Co. Inc. (related party)              |   | June 6, 2010                   |   | June 19, 2013      |   | $                | 100,000 |               | 10 % per annum       |                              | $      | 50,000 |   |
|                                                         |   |                           |   |               |   |             |    |               |                 |                              |   |   |   |
| Mr. Pavel Alpatov, controlling shareholder and related party |   | October 8, 2010                |   | October 7, 2020    |   | $                | 100,000 |               | 10 % per annum       |                              | $      | 99,970 |   |
|                                                         |   |                           |   |               |   |             |    |               |                 |                              |   |   |   |
| Mr. Pavel Alpatov, controlling shareholder and related party |   | February 15, 2011              |   | February 15, 2021  |   | $                | 400,000 |               | 10 % per annum  |                              | $      | 399,985 |   |
|                                                         |   |                           |   |               |   |             |    |               |                 |                              |   |   |   |
| Total                                                        |   |                           |   |               |   |             |    |               |                 |                              | $      | 549,955 |   |

----

----

|   | (a) | Loan from Pavel Alpatov. On February 15, 2011, the Company entered into a Loan Agreement with Pavel Alpatov, President and Principal Executive officer of the Company, as Lender, and the Company, as Borrower. Under the Loan Agreement, Mr. Alpatov agreed to lend the Company a maximum of $400,000, available in one drawing of a total amount of $400,000 at any time prior to February 15, 2021. Outstanding principal will bear interest at a rate of 10% per annum. All outstanding principal and accrued interest is due no later than February 15, 2021. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b)  | Office Lease.  On April 06, 2011, the Company entered into an Office Lease Agreement with Property Reserve, Inc., pursuant to which it would rent 858 square feet at 3655 Nobel Drive, Suite 520, San Diego, CA 92122.  The Company has moved its headquarters to such location.  The term of the Office Lease is one year, and the base rent is $2,016.30 per month.  The sum of $24,195.60, presenting the base rent for the full 12-month term was paid by the Company upon execution of the Office Lease Agreement. |
|--------|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | Exclusive Distribution and Marketing Agreement. On April 4, 2011, the Company entered into an Exclusive Distribution and Marketing Agreement with CJSC-Innovation Weapons Technologies (“Distributor”) pursuant to which Distributor will serve as the exclusive distributor in the Russian Federation for all products to be produced by the Company. As exclusive distributor for the Company’s products in the Russian Federation, Distributor will be entitled to purchase the products sold at Distributor’s cost. The Exclusive Distribution and Marketing Agreement will have an initial term of seven years. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d)  | Manufacturing Agreement.  On April 4, 2011, the Company entered into a Manufacturing Agreement with CJSC-Innovation Weapons Technologies (“Manufacturer”) pursuant to which Manufacturer will produce various products or its parts for the Company.  The Manufacturing Agreement will have an initial term of five years. |
|--------|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | NAME              |   | OFFICE                      | DATE         |
|--------|-------------------|--------|-----------------------------|--------------|
|   |              |   |                        |         |
|   | /s/ Pavel Alpatov |   | President                   | May 20, 2011 |
|   | Pavel Alpatov     |   | Principal Executive Officer |         |
|   |              |   | Principal Financial Officer |         |

----